Drug delivery system is therapeutic agent release regulated. Drug Delivery System tracks the delivery of the drug and its position in the body where it is delivered. The forthcoming drug delivery technologies include work in the areas of brain, illness and diseases crossing the Blood-Brain Barrier (BBB), optimizing targeted intracellular delivery, integrating diagnosis and treatment. Drug delivery probably has a major effect on retinal disease management. There are a large range of medications that are relatively successful in treating retinal disorders, but they are constrained by issues of delivery such as the need for the molecule to cross the blood-eye barrier, to be present for long periods of time, or the need to reduce side effects.
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters & Accepted Abstracts: Journal of Bioprocessing & Biotechniques
Posters-Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report